Literature DB >> 16330027

Neuronal clues to vascular guidance.

Steven Suchting1, Roy Bicknell, Anne Eichmann.   

Abstract

The development of the vertebrate vascular system into a highly ordered and stereotyped network requires precise control over the branching and growth of new vessels. Recent research has highlighted the important role of genetic programs in regulating vascular patterning and in particular has established a crucial role for families of molecules previously described in controlling neuronal guidance. Like neurons, new vessels are guided along the correct path by integrating attractive and repulsive cues from the external environment. This is achieved by specialised endothelial cells at the leading tip of vessel sprouts which express receptor proteins that couple extracellular guidance signals with the cytoskeletal changes necessary to alter cell direction. Here, we review the genetic and in vitro evidence implicating four families of ligand-receptor signalling systems common to both neuronal and vessel guidance: the Ephrins and Eph receptors; Semaphorins, Neuropilins and Plexin receptors; Netrin and Unc5 receptors; and Slits and Robo receptors.

Mesh:

Substances:

Year:  2005        PMID: 16330027     DOI: 10.1016/j.yexcr.2005.11.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  43 in total

Review 1.  NFAT signaling in neural development and axon growth.

Authors:  Tuan Nguyen; Simone Di Giovanni
Journal:  Int J Dev Neurosci       Date:  2007-11-17       Impact factor: 2.457

Review 2.  Cell lineages and early patterns of embryonic CNS vascularization.

Authors:  Haymo Kurz
Journal:  Cell Adh Migr       Date:  2009-04-16       Impact factor: 3.405

Review 3.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

4.  Slit2 overexpression results in increased microvessel density and lesion size in mice with induced endometriosis.

Authors:  Sun-Wei Guo; Yu Zheng; Yuan Lu; Xishi Liu; Jian-Guo Geng
Journal:  Reprod Sci       Date:  2012-08-08       Impact factor: 3.060

5.  Collateral vessel growth induced by femoral artery ligature is impaired by denervation.

Authors:  Ming-Ying Luo; Bao-Lin Yang; Feng Ye; Xiaoqiong Wu; Song Peng; Bin Yi; Wei Wang; Wu Zhu; Hua Luo; Jian-Guo Wen; Wei-Jun Cai; Jutta Schaper; Wolfgang Schaper
Journal:  Mol Cell Biochem       Date:  2011-04-21       Impact factor: 3.396

6.  Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.

Authors:  Yung Hae Kim; Huiqing Hu; Salvador Guevara-Gallardo; Michael T Y Lam; Shun-Yin Fong; Rong A Wang
Journal:  Development       Date:  2008-11       Impact factor: 6.868

7.  Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects.

Authors:  Ying Zhang; Manvendra K Singh; Karl R Degenhardt; Min Min Lu; Jean Bennett; Yutaka Yoshida; Jonathan A Epstein
Journal:  Dev Biol       Date:  2008-10-17       Impact factor: 3.582

8.  Resolution of defective dorsal aortae patterning in Sema3E-deficient mice occurs via angiogenic remodeling.

Authors:  Stryder M Meadows; Lyndsay A Ratliff; Manvendra K Singh; Jonathan A Epstein; Ondine Cleaver
Journal:  Dev Dyn       Date:  2013-03-29       Impact factor: 3.780

9.  Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.

Authors:  Xialin Liu; Yongjun Li; Yizhi Liu; Yan Luo; Dingding Wang; Brian H Annex; Pascal J Goldschmidt-Clermont
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

10.  Differential expression of anti-angiogenic factors and guidance genes in the developing macula.

Authors:  Peter Kozulin; Riccardo Natoli; Keely M Bumsted O'Brien; Michele C Madigan; Jan M Provis
Journal:  Mol Vis       Date:  2009-01-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.